Some patients benefit from staying on GLP-1 therapy longer to maximize these systemic improvements, even after reaching weight goals
Catwalk gait analysis Gait was captured using the catwalk gait analysis system 7.1 (Noldus)
Heliyon 2025:1 remi N, remi MM (2025) Oxidative/nitrosative stress, apoptosis, and redox signaling: key players in neurodegenerative diseases
Association Between Different GLP-1 Receptor Agonists and Gastrointestinal Adverse Reactions: A Real-World Disproportionality Study Based on FDA Adverse Event Reporting System Database. Frontiers in Endocrinology
According to the same survey, Awareness of GLP-1 drugs has increased in the past year, with about one-third (32%) of adults now saying they have heard a lot about these drugs, up from 19% in July 2023. Fifty-four percent of people who took a GLP drug said it was difficult to afford and it is often reported that, although doctors recommend staying on these drugs for a lifetime, many abandon them after a year
Made in Australia